115 related articles for article (PubMed ID: 2139189)
1. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
Alam AM; Starr MS
Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
[TBL] [Abstract][Full Text] [Related]
3. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
4. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
[TBL] [Abstract][Full Text] [Related]
5. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
6. D1 and D2 dopamine receptor interactions with pilocarpine-induced oral activity in rats.
Levin ED; Ellison GD; See RE; South D; Young E
Pharmacol Biochem Behav; 1989 Jul; 33(3):501-5. PubMed ID: 2573903
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
Subramaniam S; Lucki I; McGonigle P
Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
[TBL] [Abstract][Full Text] [Related]
8. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
[TBL] [Abstract][Full Text] [Related]
9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine.
Barone P; Palma V; DeBartolomeis A; Tedeschi E; Muscettola G; Campanella G
Eur J Pharmacol; 1991 Mar; 195(1):157-62. PubMed ID: 1829682
[TBL] [Abstract][Full Text] [Related]
12. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
Asin KE; Bednarz LM
Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
al-Tajir G; Chandler CJ; Starr BS; Starr MS
Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
[TBL] [Abstract][Full Text] [Related]
15. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
Williams JE; Woolverton WL
Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
Stittsworth JD; Mueller AL
Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Robertson GS; Robertson HA
Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
Maslowski RJ; Napier TC
Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
Ross SB; Jackson DM; Wallis EM; Edwards SR
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
